http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2499262-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_017fb04fe92d3ee805c0280894bad8e8 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2012-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f72f64e42d68fae15d5c22c58096cb78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65865c0e7589dbf6ee5253068ac43601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29e08a99a520e54687b17dc4f74c72c |
publicationDate | 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2499262-C1 |
titleOfInvention | Method for prediction of epilepsy severity |
abstract | FIELD: medicine. n SUBSTANCE: patients' blood serum is examined for the pre-therapeutic mean molecule spectrum. If a mean molecule fraction described as an optical absorption E at wave length 230 nm is below 0.118 standard units, and a nuclear-peptide index described as a relation of the optical absorption E at wave length 230 nm to the optical absorption E at wave length 254 nm is below 0.8, the severe clinical course of epilepsy is predicted. n EFFECT: using the declared method enables the more accurate prediction of the clinical course of epilepsy. n 1 tbl, 2 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2787512-C1 |
priorityDate | 2012-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.